We are live on ! Find out more
FCMT

Founders Capital Management (Texas) Portfolio holdings

AUM $231M
1-Year Est. Return 61.68%
This Fund
S&P 500
This Quarter Est. Return
+7.61%
1 Year Est. Return
+61.68%
3 Year Est. Return
+118.08%
5 Year Est. Return
+149.3%
10 Year Est. Return
AUM
$132M
AUM Growth
+$7.11M
Cap. Flow
-$944K
Cap. Flow %
-0.71%
Top 10 Hldgs %
44.8%
Holding
333
New
9
Increased
45
Reduced
44
Closed
16

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$2.27M
2
COP icon
ConocoPhillips
COP
+$1.18M
3
HAL icon
Halliburton
HAL
+$317K
4
MSFT icon
Microsoft
MSFT
+$307K
5
OXY icon
Occidental Petroleum
OXY
+$193K

Sector Composition

Rank Sector Weight
1 Technology 23.29%
2 Industrials 13.15%
3 Energy 11.77%
4 Healthcare 10.71%
5 Consumer Discretionary 8.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAD
326
DELISTED
Rite Aid Corporation
RAD
-132
Closed -$1K
FVL
327
DELISTED
First TrustValue Line 100 Exchange-Traded
FVL
-85
Closed -$2K
PGNX
328
DELISTED
Progenics Pharmaceuticals Inc
PGNX
-1,000
Closed -$5K
TERP
329
DELISTED
TerraForm Power, Inc
TERP
$0 ﹤0.01%
14
RVLT
330
DELISTED
Revolution Lighting Technologies, Inc. - Class A
RVLT
-2,000
Closed
OHAI
331
DELISTED
OHA Investment Corporation
OHAI
-6,000
Closed -$8K
TVIX
332
DELISTED
VelocityShares Daily 2x VIX Short Term ETN
TVIX
-6
Closed -$1K
KEG
333
DELISTED
Key Energy Services, Inc. Common Stock
KEG
-300
Closed

Similar funds

Founders Capital Management (Texas)'s Q4 2019 Portfolio in Review

As of Q4 2019, Founders Capital Management (Texas) held 333 positions worth $132M, up 5.7% from $125M the previous quarter. Its ten largest holdings account for 45% of the portfolio.

Founders Capital Management (Texas)'s Q4 2019 filing shows 9 new, 45 increased, 44 reduced and 16 closed positions. Its largest new stake was CVS Health: 503 shares worth $37K. The largest sale was Amgen, an estimated $2.27M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Energy.

  • Founders Capital Management (Texas)'s largest Q4 2019 buy was CVS Health: 503 shares worth $37K.
  • Founders Capital Management (Texas) added most to AbbVie in Q4 2019, an estimated $744K increase.
  • Founders Capital Management (Texas)'s biggest Q4 2019 reduction was Microsoft, cutting an estimated $307K.
  • Founders Capital Management (Texas) fully exited Amgen in Q4 2019, selling an estimated $2.27M.
  • Founders Capital Management (Texas)'s ten largest holdings make up 45% of its $132M portfolio in Q4 2019.
  • Founders Capital Management (Texas) opened 9 new positions and closed 16 in Q4 2019.
  • Founders Capital Management (Texas)'s portfolio value rose 5.7% quarter-over-quarter to $132M.

Based on Founders Capital Management (Texas)'s 13F filing for Q4 2019, filed 24 Jan 2020.